Benzinga | Nov 5, 2020 05:22PM EST

Cormedix Q3 EPS $(0.22) Beats $(0.25) Estimate, Sales $93.02K Beat $40.00K Estimate

Cormedix (AMEX:CRMD) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.25) by 12 percent. This is unchanged from the same period last year. The company reported quarterly sales of $93.02 thousand which beat the analyst consensus estimate of $40.00 thousand by 132.55 percent. This is a 56.26 percent increase over sales of $59.53 thousand the same period last year.